Lab monitoring on TRT: what the evidence actually requires

What did @gamedaybostoninnerwest actually say?

The creator disclosed that his testosterone tested at 1500 ng/dL while on TRT, acknowledged he "plays around" with his protocols, and listed symptoms of excessive testosterone including palpitations, high blood pressure, sweats, oily skin, and acne. He described his clinic's policy of only prescribing testosterone to patients who are below a therapeutic threshold and showing signs of hypogonadism. He also detailed a first-year monitoring cadence of labs at one, three, six, and twelve months.

Worth noting: he called the heart symptom "hot palpitations," which is not a clinical term. He likely meant cardiac palpitations, possibly combined with heat intolerance. It reads like a slip of the tongue rather than a fabricated claim, but precision matters when you're running a healthcare clinic on TikTok.

Does the science back this up?

On monitoring frequency, yes, broadly. The 2018 American Urological Association guideline recommends checking hematocrit, testosterone levels, and a PSA at three to six months after starting TRT, then annually. The creator's schedule is more aggressive than that minimum, which is not a bad thing.

On the symptom list for high testosterone, the evidence is real but nuanced. Erythrocytosis (elevated red blood cell mass) is one of the most documented risks of supraphysiologic testosterone, raising cardiovascular risk (Ohlander et al., 2018, European Urology). Acne and oily skin are well-established androgenic effects. Hypertension and palpitations are plausible at very high levels, though the direct causal chain is less straightforward than the video implies. A level of 1500 ng/dL sits above the upper limit of most lab reference ranges (typically 900-1000 ng/dL), and the Endocrine Society's 2018 guidelines explicitly caution against targeting supraphysiologic levels.

What did they get wrong or right?

The creator deserves credit for one thing most TRT content creators avoid: he admitted his own levels were high and framed that as a problem to manage, not a flex. That's genuinely more responsible than a lot of what circulates in this space.

What's less defensible is the phrase "plays around" with his protocols. Self-adjusting TRT without clinical supervision is how patients end up with cardiovascular events. If he's doing this under medical oversight, he should say so clearly. If he's not, his clinic's careful monitoring pitch rings hollow when the spokesperson is DIY-titrating his own dose.

His symptom list is mostly accurate, but calling 1500 ng/dL something that can make you "feel pretty bad" undersells the documented risks at supraphysiologic levels. Hematocrit elevation, polycythemia, and increased thrombotic risk are not just comfort issues (Glueck et al., 2016, Clinical and Applied Thrombosis/Hemostasis).

What should you actually know?

Frequent lab monitoring during TRT is genuinely good clinical practice, and any provider skipping it is cutting corners. The standard minimum is a full panel including total testosterone, hematocrit, PSA, and a metabolic panel at three to six months after initiation, then annually if stable (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism).

A level of 1500 ng/dL is above what most guidelines consider safe for long-term management. The Endocrine Society recommends targeting mid-normal physiologic range, roughly 400 to 700 ng/dL, not supraphysiologic peaks. Patients should ask their provider what their target range is and why, not just whether they're getting labs done.

Red flags in any TRT clinic include no baseline labs before prescribing, no follow-up monitoring, and providers who set testosterone targets based on "how you feel" without objective data. The creator's clinic framework, if it operates as described, is closer to guideline-concordant care than many telehealth competitors. That doesn't mean every claim in the video is precise.